Peyronie's Disease

Standard Practice in Sexual Medicine

Volumn , Issue , 2008, Pages 158-173

  Nehra, Ajay ^a   Mulhall, John ^b,c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Autoimmune etiology; Genetics; Immunity; Pathophysiology; Peyronie's disease

Indexed keywords

EID: 84889380510     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470755235.ch14     Document Type: Chapter

References (117)

1. Gelbard M. Peyronie's disease. In: Hashmat AI, Das S, eds. The Penis. Philadelphia: Lea and Febiger, 1993, pp. 244-365.
2. Carrier S, Lue TF. For Peyronie's disease, act conservatively. Contemporary Urol 1994;9:54-65.
3. Pryor JP. The management of Peyronie's disease. In Porst H, ed. Penile Disorders. Proceedings of the International Symposium on Penile Disorders, Hamburg, Germany, January 26-27, 1996. Berlin: Springer Verlag, 1997, pp. 75-86.
4. Devine CJ, Horton CE. Peyronie's disease. Clin Plast Surg 1988;15:405-409.
5. Jarow JP, Lowe FC. Penile trauma: An etiologic factor in Peyronie's disease and erectile dysfunction. J Urol 1997;158:1388-1390.
6. Devine CJ, Somers KD, Jordan GH, Schlossberg SM. Proposal: Trauma as a cause of Peyronie's lesion. J Urol 1997;157:285-290.
7. Vande Berg JS, Devine CJ, Horton CE, Somers KD, Wright GL, Leffel MS, Dawson DM, Gleischman SH, Rowe MJ. Mechanisms of calcification in Peyronie's disease. J Urol 1982;127:52-54.
8. Krane RJ. The treatment of loss of penile rigidity associated with Peyronie's disease. Scand J Urol Nephrol Suppl 1997;179:147-150.
9. Gasior BL, Levine FJ, Howannesian A, Krane RJ, Goldstein I. Plaque-associated corporal veno-occlusive dysfunction in idiopathic Peyronie's disease: a pharmacocavernosometric and pharmacocavernosographic study. World J Urol 1990;8:90-97.
10. Lopez JA, Jarow JP. Penile vascular evaluation of men with Peyronie's disease. J Urol 1993;149:53-55.
11. Lyles KW, Gold DT, Newton RA, Parekh S, Shipp KM, Pieper CF, Krishan R, Carson CC. Peyronie's disease is associated with Paget's disease of the bone. J Bone Miner Res 1997;12:929-934.
12. Nyberg LM, Bias WB, Hochberg MC, Walsh PC. Identification of an inherited form of Peyronie's disease with an autosomal dominant inheritance and association with Dupuytren's contracture and histocompatability B7 cross-reactive antigens. J Urol 1982;128:48-52.
13. Ralph DJ, Schwartz G, Moore W, Pryor JP, Ebringer A, Bottazzo GF. The genetic and bacteriological aspects of Peyronie's disease. J Urol 1997;157:291-294.
14. Leffell MS. Is there an immunogenetic basis for Peyronie's disease? J Urol 1997;157:295-297.
15. Schiavino D, Sasso F, Nucera E, Alcini E, Gulino G, Milani A, Patriarca G. Immunologic findings in Peyronie's disease: a controlled study. Urology 1997;50:764-768.
16. Stewart S, Malto M, Sandberg L, Colburn KK. Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease. J Urol 1994;152:105-106.
17. Diegelmann RF. Cellular and biochemical aspects of normal and abnormal wound healing: an overview. J Urol 1997;157:298-302.
18. Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT. The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J Urol 1991;146:1007-1009.
19. Smith BH. Subclinical Peyronie's disease. Am J Clin Pathol 1969;52:385-390.
20. Zarafonetis CJD, Horran TM. Treatment of Peyronie's disease with potassium para-aminobenzoate (POTABA). J Urol 1959;81:770-772.
21. Scott WW, Scardino PL. A new concept in the treatment of Peyronie's disease. South Med J 1948;41:173-177.
22. Gelbard MK, Dorey F, James K. The natural history of Peyronie's disease. J of Urol 1990;144(6):1376-1379.
23. Akkus E, Carrier S, Rehman J, et al. Is colchicine effective in Peyronie's disease? A pilot study Urology 1994;44(2):291-295.
24. Kadioglu A, Tefekli A, Koksal T, et al. Treatment of Peyronie's disease with potassium oral colchicine: Long-term results and predictive parameters of successful outcome. Int J Impot Res 2000;12(3):169-175.
25. Zarafonetis CJ, Jorrax TM. Treatment of Peyronie's disease with potassium para-aminobenzoate (Potaba). J of Urol 1959;81(6):770-772.
26. Hasche-Klunder R. Treatment of Peyronie's disease with para-aminobenzoacidic potassium (Potaba) (author's transl). Urologe A 1978;17(4):224-227.
27. Weidner W, Schroeder-Printzen I, Rudnick J, et al. Randomized prospective placebo-controlled therapy of Peyronie's disease (IPP) with Potaba (aminobenzoate potassium). J Urol 1999;6(4 suppl):205. Abstract 785.
28. Ralph DJ, Rooks MD, Bottazzo GF, et al. The treatment of Peyronie's disease with tamoxifen. Br J Urol 1992;70(6):648-651.
29. Teloken C, Rhoden EL, Grazziotin TM, et al. Tamoxifen versus placebo in the treatment of Peyronie's disease. J Urol 1999;162(6):2003-2005.
30. Biagiotti G, Cavallini G. Acetyl-L-camitine versus tamoxifen in the oral therapy of Peyronie's disease: A preliminary report. BJU Int 2001;88(1):63-67.
31. Martin DJ, Badwan K, Parker M, et al. Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea. J Urol 2002;168(6): 2483-2485.
32. Teasley GH. Peyronie's Disease: A new approach. J Urol 1954;71(5):611-614.
33. Bodner H, Howard AH, Kaplan JH. Peyronie's disease: cortisone-hyaluronidase-hydrocortisone therapy. J Urol 1954;72:400-431.
34. Winter CC, Khanna R. Peyronie's Disease: Results with demo-jet injection of dexamethasone J Urol 1975;14:898-900.
35. Williams G, Green NA. The non-surgical treatment of Peyronie's disease. Br J Urol 1980;52:392-395.
36. Gelbard MK, Walsh R, Kaufman JJ. Collagenase for Peyronie's disease: Experimental studies Urol Res 1982;10:135-140.
37. Gelbard MK, James K, Riach P, et al. Collagenase versus placebo in the treatment of Peyronie's disease: A double-blind study. J Urol 1993;149(1):56-58.
38. Levine LA, Merrick PF, Lee RC. Intralesional verapamil injection for the treatment of Peyronie's disease. J Urol 1994;151(6):1522-1524.
39. Rehman J, Benet A, Melman A. Use of intralesional verapamil to dissolve Peyronie's disease plaque: A longterm single-blind study. Urology 1998;51(4):620-626.
40. Levine LA, Goldman KE, Greenfield JM. Experience with intraplaque injection of verapamil for Peyronie's disease. J Urol 2002;168(2):621-625.
41. Duncan MR, Berman B, Nseyo UO. Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferonsalpha, -beta, and -gamma. Scand J Urol Nephrol 1991;25(2):89-94.
42. Wegner HE, Andresen R, Knispel HH, et al. Treatment of Peyronie's disease with local interferon-alpha 2b. Eur Urol 1995;28(3):236-240.
43. Wegner HE, Andresen R, Knispel HJ, et al. Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease. Eur Urol 1997;32(2): 190-193.
44. Ahuja S, Bivalacqua TJ, Case J, et al. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2b in the treatment of Peyronie's disease. J Androl 1999;20(4):444-448.
45. Dang G, Matern R, Bivalacqua TJ, et al. Intralesional interferon-alpha 2b injections for the treatment of Peyronie's disease. South Med J 2004;97(1):42-46.
46. Hellstrom W, Eichenberg C, Pryor JL, et al. A singleblind, multi-center, placebo-controlled study to assess the safety and efficacy of intralesional interferon alpha-2b in the non-surgical treatment of Peyronie's disease. J Urol 2003;169(4 suppl):274 Abstract 1065.
47. Hauck EW, Altinkilic BM, Ludwig M, et al. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: First results of a case-controlled approach. Eur Urol 2000;38(6):663-669.
48. Di Stasi SM, Giannantoni A, Cappeli G, et al. Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. BJU Int 2003;91(9):825-829.
49. Di Stasi SM, Giannantoni A, Stephen RL, et al. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. J Urol 2004;171(4): 1605-1608.
50. Prieto Castro RM, Leva Vallejo ME, Regueiro Lopez JC, et al. Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease. BJU Int 2003;91(6):522-524.
51. Mirone V, Palmieri A, Granata AM, et al. Ultrasoundguided ESWT in Peyronie's disease plaques. Arch Ital Urol Androl 2000;72(4):384-387.
52. Cavallini G, Biagiotti G, Koverech A, et al. Oral propionyl-l-camitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease. BJU Int 2002;89(9):895-900.
53. Ciancio SJ, Kim ED. Penile fibrotic changes after radical retropubic prostatectomy. BJU Int 2000;85: 101-106.
54. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: Results of a large survey. BJU Int 2001;88:727-730.
55. Rhoden E, Teloken C, Ting H, Lucas M, Teodosio D, Ros C, Ary Vargas Souto C. Prevalence of Peyronie's disease in men over 50 years old from southern Brazil. Int J Impot Res 2001;13:291-293.
56. La Pera G, Pescatori E, Calabrese M, Boffini A, Colombo F, Andriani E, Natali A, Vaggi L, Catuogno C, Giustini M, Taggi F, SIMONA study group. Peyronie's disease: prevalence and association with cigarette smokin. A multicenter population-based study in men aged 50-69 Years. Eur Urol 2001;40:525-530.
57. Sommer F, Schwarzer U, Wassmer G, Bloch W, Braun M, Klotz T, Engelmann U. Epidemiology of Peyronie's disease. Int J Impot Res 2002;14:379-383.
58. Perinchery G, El-Sakka A, Angan A, Nakajima K, Dharia A, Tanaka Y, Lue T, Dahiya R. Microsatellite alterations and loss of heterozygosity in Peyronie's disease. J Urol 2000;164:842-846.
59. Mulhall J, Thom J, Lubrano T, Shankey T. Basic fibroglast growth factor expression in Peyronie's disease. J Urol 2001;165:419-423.
60. Ralph DJ, Minhas S. The management of Peyronie's disease. BJU Int 2004;93:208.
61. Hellstrom WJ, Usta MF. Surgical approaches for advanced Peyronie's disease patients. Int J Impot Res 2003;15 S5:S121.
62. Chang JA, Gholami SS, Lue TF. Surgical management: saphenous vein grafts. Int J Impot Res 2002;14:375.
63. Krishnamurti S. Penile dermal flap for defect reconstruction in Peyronie's disease: Operative technique and four years' experience in 17 patients. Int J Impot Res 1995;7:195.
64. Mulhall JP, Ahmed A, Anderson M. Penile prosthetic surgery for peyronie's disease: defining the need for intra-operative adjuvant maneuvers. J Sex Med 2004;1:318.
65. Wilson SK, Delk JR, 2nd. A new treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis. J Urol 1994;152:1121.
66. Montague DK, Angermeier KW, Lakin MM, et al. AMS 3-piece inflatable penile prosthesis implantation in men with Peyronie's disease: comparison of CX and Ultrex cylinders. J Urol 1996;156:1633.
67. Wilson SK, Cleves MA, Delk JR, 2nd. Long-term followup of treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis. J Urol 2001;165:825.
68. Bokarica P, Parazajder J, Mazuran B, et al. Surgical treatment of Peyronie's disease based on penile length and degree of curvature. Int J Impot Res 2005;17:170.
69. Rolle L, Tamagnone A, Timpano M, et al. The Nesbit operation for penile curvature: an easy and effective technical modification. J Urol 2005;173:171.
70. Navalon Verdejo P, Zaragoza Fernandez C, Sanchez Ballester F, et al. Correction of the penile curvature in ambulatory surgery. Actas Urol Esp 2005;29:217.
71. Savoca G, Scieri F, Pietropaolo F, et al. Straightening corporoplasty for Peyronie's disease: a review of 218 patients with median follow-up of 89 months. Eur Urol 2004;46:610.
72. Portillo Martin JA, Correas Gomez MA, Rado Velasquez MA, et al. Corrective surgery of penile inward curvature. Actas Urol Esp 2003;27:97.
73. Rodriguez Tolra J, Franco Miranda E, Prats Puig JM, et al. Treatment with the Newbit technique in patients with Peyronie's disease. Actas Urol Esp 2003;27: 803.
74. Syed AH, Abbasi Z, Hargreave TB. Nesbit procedure for disabling Peyronie's curvature: a median follow-up of 84 months. Urology 2003;61:999.
75. Savoca G, Trombetta C, Ciampalini S, et al. Long-term results with Nesbit's procedure as treatment of Peyronie's disease. Int J Impot Res 2000;12:289.
76. Pryor JP. Correction of penile curvature and Peyronie's disease: why I prefer the Nesbit technique. Int J Impot Res 1998;10:129.
77. Rehman J, Benet A, Minsky LS, et al. Results of surgical treatment for abnormal penile curvature: Peyronie's disease and congenital deviation by modified Nesbit plication (tunical shaving and plication). J Urol 1997;157:1288.
78. Ralph DJ, al-Akraa M, Pryor JP. The Nesbit operation for Peyronie's disease: 16-year experience. J Urol 1995;154:1362.
79. Sulaiman MN, Gingell JC. Nesbit's procedure for penile curvature. J Androl 1994;15 S:54S.
80. Van Der Horst C, Martinez Portillo FJ, Seif C, et al. Treatment of penile curvature with Essed-Schroder tunical plication: aspects of quality of life from the patients' perspective. BJU Int 2004;93:105.
81. Gholami SS, Lue TF. Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol 2002;167:2066.
82. van der Drift DG, Vroege JA, Groenendijk PM, et al. The plication procedure for penile curvature: surgical outcome and postoperative sexual functioning. Urol Int 2002;69:120.
83. Chahal R, Gogoi NK, Sundaram SK, et al. Corporal plication for penile curvature caused by Peyronie's disease: the patients' perspective. BJU Int 2001;87: 352.
84. Thiounn N, Missirliu A, Zerbib M, et al. Corporeal plication for surgical correction of penile curvature. Experience with 60 patients. Eur Urol 1998;33:401.
85. Levine LA. Treatment of Peyronie's disease with intralesional verapamil injection. J Urol 1997;158: 1395.
86. Kummerling S, Schubert J. Peyronie's disease. Investigation of staging, erectile failure and operative management. Int Urol Nephrol 1995;27:629.
87. Nooter RI, Bosch JL, Schroder FH. Peyronie's disease and congenital penile curvature: long-term results of operative treatment with the plication procedure. Br J Urol 1994;74:497.
88. Klevmark B, Andersen M, Schultz A, et al. Congenital and acquired curvature of the penis treated surgically by plication of the tunica albuginea. Br J Urol 1994;74:501.
89. Chertin B, Koulikov D, Fridmans A, et al. Dorsal tunica albuginea plication to correct congenital and acquired penile curvature: a long-term follow-up. BJU Int 2004;93:379.
90. Chien GW, Aboseif SR. Corporeal plication for the treatment of congenital penile curvature. J Urol 2003;169: 599.
91. Hauck EW, Bschleipfer T, Diemer T, et al. Long-term results of Essed-Schroeder plication by the use of nonabsorbable Goretex sutures for correcting congenital penile curvature. Int J Impot Res 2002;14:146.
92. Ebbehoj J, Metz P. Congenital penile angulation. Br J Urol 1987;60:264.
93. Kalsi J, Minhas S, Christopher N, et al. The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease. BJU Int 2005;95:1029.
94. Shioshvili TJ, Kakonashvili AP. The surgical treatment of Peyronie's disease: replacement of plaque by free autograft of buccal mucosa. Eur Urol 2005;48:129.
95. Levine LA, Estrada CR. Human cadaveric pericardial graft for the surgical correction of Peyronie's disease. J Urol 2003;170:2359.
96. Hatzichristou DG, Hatzimouratidis K, Apostolidis A, et al. Corporoplasty using tunica albuginea free grafts for penile curvature: surgical technique and long-term results. J Urol 2002;167:1367.
97. Schwarzer JU, Muhlen B, Schukai O. Penile corporoplasty using tunica albuginea free graft from proximal corpus cavernosum: a new technique for treatment of penile curvature in Peyronie's disease. Eur Urol 2003;44:720.
98. Hsu YS, Huang WJ, Kuo JY, et al. Experience of surgical treatment of peyronie's disease with deep dorsal venous patch graft in Taiwanese men. J Chin Med Assoc 2003;66:487.
99. Egydio PH, Lucon AM, Arap S. Treatment of Peyronie's disease by incomplete circumferential incision of the tunica albuginea and plaque with bovine pericardium graft. Urology 2002;59:570.
100. Sampaio JS, Fonseca J, Passarinho A, et al. Peyronie's disease: surgical correction of 40 patients with relaxing incision and duramater graft. Eur Urol 2002;41: 551.
101. Adeniyi AA, Goorney SR, Pryor JP, et al. The Lue procedure: an analysis of the outcome in Peyronie's disease. BJU Int 2002;89:404.
102. Hauck EW, Bschleipfer T, Diemer T, et al. Long-term results of plaque thinning with carbide burs, small incisions and venous grafting for correcting complex penile curvature in Peyronie's disease: poor results of an "ideal" approach. J Urol 2002;167:2070.
103. Knoll LD. Use of porcine small intestinal submucosal graft in the surgical management of Peyronie's disease. Urology 2001;57:753.
104. Akkus E, Ozkara H, Alici B, et al. Incision and venous patch graft in the surgical treatment of penile curvature in Peyronie's disease. Eur Urol 2001;40:531.
105. Teloken C, Grazziotin T, Rhoden E, et al. Penile straightening with crural graft of the corpus cavernosum. J Urol 2000;164:107.
106. Montorsi F, Salonia A, Maga T, et al. Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease. J Urol 2000;163: 1704.
107. Kadioglu A, Tefekli A, Usta M, et al. Surgical treatment of Peyronie's disease with incision and venous patch technique. Int J Impot Res 1999;11:75.
108. El-Sakka AI, Rashwan HM, Lue TF. Venous patch graft for Peyronie's disease. Part II: outcome analysis. J Urol 1998;160:2050.
109. Akin-Olugbade Y, Ahmed A, Parker M, Patricia Guhring, Mulhall JP. Determinants of patient satisfaction following penile prosthesis surgery. J Sex Med 2005.
110. Usta MF, Adams DM, Zhang JW, et al. Penile epithelioid sarcoma and the case for a histopathological diagnosis in Peyronie's disease. BJU Int 2003;91:519.
111. Levine LA, Estrada CR, Morgentaler A. Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study. J Urol 2001;166:932.
112. Levine LA, Dimitriou RJ. A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie's disease. Int J Impot Res 2000;12:147.
113. Carson CC. Penile prosthesis implantation in the treatment of Peyronie's disease and erectile dysfunction. Int J Impot Res 2000;12 S4:S122.
114. Ghanem HM, Fahmy I, el-Meliegy A. Malleable penile implants without plaque surgery in the treatment of Peyronie's disease. Int J Impot Res 1998;10:171.
115. Morganstern SL. Long-term experience with the AMS 700CX inflatable penile prosthesis in the treatment of Peyronie's disease. Tech Urol 1997;3:86.
116. Marzi M, Zucchi A, Lombi R, et al. Implant surgery in Peyronie's disease. Urol Int 1997;58:113.
117. Montorsi F, Guazzoni G, Barbieri L, et al. AMS 700 CX inflatable penile implants for Peyronie's disease: functional results, morbidity and patient-partner satisfaction. Int J Impot Res 1996;8:81.